MyMD Pharmaceuticals, Inc. (MYMD)

NASDAQ: MYMD · IEX Real-Time Price · USD

2.520

+0.270 (12.00%)

At close: Apr 18, 2024, 4:00 PM

2.500

-0.020 (-0.79%)

Pre-market: Apr 19, 2024, 8:00 AM EDT

MyMD Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Revenue	0	0	0	0	0	1.67	3.35	2.96	2.12	4.43	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-50.35%	13.30%	39.99%	-52.23%	23.74%	Upgrade
Cost of Revenue	0	0	0	0	0	1.54	2.41	1.08	0.95	1.18	Upgrade
Gross Profit	0	0	0	0	0	0.13	0.95	1.88	1.16	3.25	Upgrade
Selling, General & Admin	5.44	5.52	6.42	2.95	3.4	7.45	6.13	5.15	6.57	5.28	Upgrade
Research & Development	7.87	9.07	6.75	2.47	0	1.06	1.26	1.19	1.41	0.92	Upgrade
Other Operating Expenses	3.05	0.7	15.04	2.88	0.08	1.68	0.17	-1.13	2.87	0.26	Upgrade
Operating Expenses	16.36	15.28	28.2	8.3	3.47	10.19	7.56	5.21	10.85	6.46	Upgrade
Operating Income	-16.36	-15.28	-28.2	-8.3	-3.47	-10.06	-6.61	-3.33	-9.68	-3.2	Upgrade
Other Expense / Income	-12.36	-0.09	1.69	1.19	0.42	0.79	0.75	-0.03	-0.1	-0.06	Upgrade
Pretax Income	-4	-15.2	-29.89	-9.49	-3.89	-10.85	-7.37	-3.3	-9.58	-3.14	Upgrade
Income Tax	0	0	0	0	0	0	0	0	-0.27	0	Upgrade
Net Income	-4	-15.2	-29.89	-9.49	-3.89	-10.85	-7.37	-3.3	-9.31	-3.14	Upgrade
Preferred Dividends	4.22	0	0	0	0	0	0	0	0	0	Upgrade
Net Income Common	-8.22	-15.2	-29.89	-9.49	-3.89	-10.85	-7.37	-3.3	-9.31	-3.14	Upgrade
Shares Outstanding (Basic)	2	1	1	1	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	1	1	0	0	0	0	0	0	Upgrade
Shares Change	19.18%	10.88%	24.23%	9101.99%	25.81%	897.05%	72.82%	5.61%	8.25%	196.40%	Upgrade
EPS (Basic)	-5.33	-11.74	-25.50	-10.20	-381.00	-1336.80	-9057.59	-7027.19	-20851.18	-7603.19	Upgrade
EPS (Diluted)	-5.33	-11.74	-25.50	-10.20	-381.00	-1336.80	-9057.59	-7027.19	-20851.18	-7603.19	Upgrade
Free Cash Flow	-12.98	-12.27	-19.52	-4.66	-3.07	-8.57	-5.13	-4.3	-5.25	-3.91	Upgrade
Free Cash Flow Per Share	-8.42	-9.48	-16.72	-4.96	-300.46	-1056.01	-6310.82	-9114.77	-11753.87	-9488.77	Upgrade
Gross Margin	-	-	-	-	-	7.64%	28.28%	63.42%	55.05%	73.45%	Upgrade
Operating Margin	-	-	-	-	-	-604.02%	-197.15%	-112.42%	-457.78%	-72.37%	Upgrade
Profit Margin	-	-	-	-	-	-651.37%	-219.58%	-111.57%	-440.27%	-70.99%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-514.56%	-153.07%	-145.11%	-248.00%	-88.29%	Upgrade
EBITDA	-4	-15.2	-29.89	-9.47	-3.81	-10.61	-7.12	-3.02	-9.28	-2.79	Upgrade
EBITDA Margin	-	-	-	-	-	-637.29%	-212.13%	-101.91%	-438.82%	-63.10%	Upgrade
Depreciation & Amortization	0	0	0	0.02	0.07	0.23	0.25	0.29	0.3	0.35	Upgrade
EBIT	-4	-15.2	-29.89	-9.49	-3.89	-10.85	-7.37	-3.3	-9.58	-3.14	Upgrade
EBIT Margin	-	-	-	-	-	-651.37%	-219.58%	-111.57%	-453.00%	-70.99%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).